UK Launches £22M AI Hub to End Animal Testing

New Cambridge hub uses AI and organoids to accelerate drug discovery and move research away from animal models.

By Kronos Digital News Desk··1 min read
A scientist in a modern laboratory monitors a digital display and 3D organoid models, representing the UK's new initiative to replace animal testing with AI and human tissue.

A scientist in a modern laboratory monitors a digital display and 3D organoid models, representing the UK's new initiative to replace animal testing with AI and human tissue.

Photo: Kronos Digital News

UK Science Minister Chris McDonald announced a £22 million investment to shift research away from animal testing [1]. The initiative funds nine high-tech projects using AI to predict how drugs behave in humans [1]. This move aims to provide patients with faster access to new medicines [1].

A central part of the plan is the Pre-clinical Translational Models Hub in Cambridge [1]. This facility will develop "organoids," which are lab-grown human tissues that mimic real organs [1]. Researchers expect these models to provide more accurate data than traditional animal studies [1].

Editorial notes

Transparency note

AI assisted drafting. Human edited and reviewed.

AI assisted
Yes
Human review
Yes
Last updated

Risk assessment

High

Risk level elevated to high because the story relies on a single primary source (GOV.UK), failing the recommendation for three independent domains.

Sources

Related stories

View all

Get the weekly briefing

A concise briefing with selected stories and analysis.

No spam. Unsubscribe anytime. By joining, you agree to our Privacy Policy.

About the author

Kronos Digital News Desk covers news and editorial analysis for Kronos Digital News.